Helixmith ranked among the top searched stocks for 7 days in the past month.


As of 9:30 AM on the 23rd, Helixmith is trading at 20,350 KRW, down 0.49% from the previous day. This represents a 44.85% decline compared to September 21. Helixmith is known as a specialized company developing new drugs focused on gene therapy.

Over the past 5 days, individual investors have net purchased 63,120 shares, while foreigners and institutions have net purchased 114,333 shares and net sold 134,843 shares, respectively.


On October 21, Helixmith became a market issue with the headline "'260 billion KRW private equity fund investment' clarification leads to 'rebound'."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing